On April 25, 2016, TLA held its third annual awards event. The I-Squared Awards for Innovation and Impact honored those whose work directly affects the quality of life for people in Tucson, across Arizona and throughout the world.

Akhu Therapeutics has licensed a UA technology that is targeted to allow doctors to relieve the symptoms of acute depression in a fraction of the time required for current therapies.

TLA is working with College of Medicine researchers on bringing a new snakebite treatment to market that may serve as a “bridge” to buy time until medical care is available.

In 2015 the College of Agriculture and Life Sciences tripled the number of executed license and option agreements, launched three start-up companies, and had a record year in IP income.

TLA recently earned a designation as an I-Corps Site. Now, teams need help defining and protecting their intellectual property. The UA College of Law IP Clinic is stepping up to help.

Startup company Yumanity Therapeutics has licensed a UA-invented prodrug and its analogues to develop treatments for neurodegenerative diseases like Alzheimer’s, Parkinson’s and ALS that affect over 55 million people.